Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer
Open accessAbstract
Arginine, a semi‐essential amino acid in humans, is critical for the growth of human cancers, particularly those marked by de novo chemoresistance and a poor clinical outcome. In addition to protein synthesis, arginine is involved in diverse aspects of tumour metabolism, including the synthesis of nitric oxide, polyamines, nucleotides, proline and glutamate. Tumoural downregulation of the enzyme argininosuccinate synthetase (ASS1), a recognised rate‐limiting step in arginine synthesis, results in an intrinsic dependence on extracellular arginine due to an inability to synthesise arginine for growth. This dependence on extracellular arginine is known as arginine auxotrophy. Several tumours are arginine auxotrophic, due to variable loss of ASS1, including hepatocellular carcinoma, malignant melanoma, malignant pleural mesothelioma, prostate and renal cancer. Importantly, targeting extracellular arginine for degradation in the absence of ASS1 triggers apoptosis in arginine auxotrophs. Several phase I/II clinical trials of the arginine‐lowering drug, pegylated arginine deiminase, have shown encouraging evidence of clinical benefit and low toxicity in patients with ASS1‐negative tumours. In part, ASS1 loss is due to epigenetic silencing of the ASS1 promoter in various human cancer cell lines and tumours, and it is this silencing that confers arginine auxotrophy. In relapsed ovarian cancer, this is associated with platinum refractoriness. In contrast, several platinum sensitive tumours, including primary ovarian, stomach and colorectal cancer, are characterised by ASS1 overexpression, which is regulated by proinflammatory cytokines. This review examines the prospects for novel approaches in the prevention, diagnosis and treatment of malignant disease based on ASS1 pathophysiology and its rate‐limiting product, arginine.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Some melanoma, lymphoma, glioma, and prostate cancers reduce or lose expression of the urea cycle enzyme argininosuccinate synthase 1.
“For example, some melanoma, lymphoma, glioma, and prostate cancers reduce or lose the expression of the urea cycle enzyme argininosuccinate synthase 1 (ASS1) (Delage et al., 2010).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Delage et al., 2010
Arginine auxotrophy of tumors is being exploited in development of anticancer therapies.
“Accordingly, the auxotrophy of tumors for arginine is being exploited in the development of anticancer therapies (Delage et al., 2010).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Delage et al., 2010
Succination is a hallmark of FH-deficient tumours.
“Succination is a hallmark of FH-deficient tumours and an antibody against succinate protein has been proposed as a diagnostic marker for HLRCC89.”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [89]
An antibody against succinate protein has been proposed as a diagnostic marker for HLRCC.
“Succination is a hallmark of FH-deficient tumours and an antibody against succinate protein has been proposed as a diagnostic marker for HLRCC89.”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [89]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Arginine metabolism: nitric oxide and beyond
WU, G., & MORRIS, S. M. (1998) · Biochemical Journal · doi:10.1042/bj3360001 · Cited by 2,811 · see citing works
Tumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337 · see citing works
Regulation of immune responses by L-arginine metabolism
Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775 · see citing works
The role of nitric oxide in tumour progression
Fukumura, D., Kashiwagi, S., & Jain, R. K. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1910 · Cited by 1,260 · see citing works
Polyamines and cancer: old molecules, new understanding
Gerner, E. W., & Meyskens, F. L. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1454 · Cited by 1,163 · see citing works
Brick by brick: metabolism and tumor cell growth
DeBerardinis, R. J., Sayed, N., Ditsworth, D., & Thompson, C. B. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.02.003 · Cited by 1,018 · see citing works
Rodrı́guez, P. C., & Ochoa, A. C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00608.x · Cited by 722 · see citing works
Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages
Xia, Y., & Zweier, J. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6954 · Cited by 691 · see citing works
Meyskens, F. L., McLaren, C. E., Pelot, D., Fujikawa-Brooks, S., Carpenter, P. M., Hawk, E. T., Kelloff, G. J., Lawson, M. J., Kidao, J., McCracken, J., et al. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0042 · Cited by 518 · see citing works
Recent advances in arginine metabolism: roles and regulation of the arginases
Morris Jr, S. M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00278.x · Cited by 485 · see citing works
Onodera, J., & Ohsumi, Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506736200 · Cited by 441 · see citing works
Autocrine Glutamate Signaling Promotes Glioma Cell Invasion
Lyons, S. A., Chung, W. J., Weaver, A. K., Ogunrinu, T., & Sontheimer, H. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2034 · Cited by 342 · see citing works
Argininosuccinate synthetase from the urea cycle to the citrulline–NO cycle
Husson, A., Brasse‐Lagnel, C., Fairand, A., Renouf, S., & Lavoinne, A. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03559.x · Cited by 329 · see citing works
Incidence and distribution of argininosuccinate synthetase deficiency in human cancers
Dillon, B. J., Prieto, V. G., Curley, S. A., Ensor, M., Holtsberg, F. W., Bomalaski, J. S., & Clark, M. A. (2004) · Cancer · doi:10.1002/cncr.20057 · Cited by 316 · see citing works
Kim, R. H., Coates, J. M., Bowles, T. L., McNerney, G. P., Sutcliffe-Goulden, J., Jung, J. U., Gandour‐Edwards, R. F., Chuang, F. Y. S., Bold, R. J., & Kung, H.-J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3157 · Cited by 316 · see citing works
Ensor, M., Holtsberg, F. W., Bomalaski, J. S., & Clark, M. A. (2002) · PubMed · Cited by 315 · see citing works
Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia
Pollock, P. M., Cohen-Solal, K., Sood, R. B., Namkoong, J., Martino, J. J., Koganti, A., Zhu, H., Robbins, C. M., Makałowska, I., Shin, S., et al. (2003) · Nature Genetics · doi:10.1038/ng1148 · Cited by 301 · see citing works
Plasma Membrane Transporters for Arginine
Closs, E. I., Simon, A., Vékony, N., & Rotmann, A. (2004) · Journal of Nutrition · doi:10.1093/jn/134.10.2752s · Cited by 297 · see citing works
Cheng, P., Lam, T. L., Lam, W.-M., Tsui, S. M., Cheng, A. W. M., Lo, W. H., & Leung, Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1945 · Cited by 279 · see citing works
The metabolism of proline, a stress substrate, modulates carcinogenic pathways
Phang, J. M., Donald, S. P., Pandhare, J., & Liu, Y. (2008) · Amino Acids · doi:10.1007/s00726-008-0063-4 · Cited by 252 · see citing works
Izzo, F., Marra, P., Beneduce, G., Castello, G., Vallone, P., De Rosa, V., Cremona, F., Ensor, C. M., Holtsberg, F. W., Bomalaski, J. S., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.120 · Cited by 250 · see citing works
Asparagine Synthetase Chemotherapy
Richards, N. G. J., & Kilberg, M. S. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142520 · Cited by 244 · see citing works
Ascierto, P. A., Scala, S., Castello, G., Daponte, A., Simeone, E., Ottaiano, A., Beneduce, G., De Rosa, V., Izzo, F., Melucci, M. T., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.0933 · Cited by 238 · see citing works
Arginine Deprivation as a Targeted Therapy for Cancer
Feun, L. G., You, M., Wu, C., Kuo, M. T., Wangpaichitr, M., Spector, S. A., & Savaraj, N. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784246199 · Cited by 235 · see citing works
Nussler, A. K., Billiar, T. R., Liu, Z. Z., & Morris, S. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42251-4 · Cited by 217 · see citing works
Metabolic enzymes as oncogenes or tumor suppressors
Thompson, C. B. (2009) · New England Journal of Medicine · doi:10.1056/nejme0810213 · Cited by 213 · see citing works
Hepatic glutamate metabolism: a tale of 2 hepatocytes
Brosnan, M. E., & Brosnan, J. T. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27462z · Cited by 199 · see citing works
Singh, R., Pervin, S., Karimi, A., Cederbaum, S. D., & Chaudhuri, G. (2000) · PubMed · Cited by 185 · see citing works
Szlosarek, P. W., Klampatsa, A., Pallaska, A., Sheaff, M. T., Smith, P., Crook, T., Grimshaw, M. J., Steele, J. P. C., Rudd, R., Balkwill, F. R., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1101 · Cited by 181 · see citing works
Self-citationYoon, C., Shim, Y., Kim, E., Lee, J., Won, N., Kim, J., Park, I., Yoon, D., & Min, B. (2007) · International Journal of Cancer · doi:10.1002/ijc.22322 · Cited by 165 · see citing works
Molecular profiling of platinum resistant ovarian cancer
Helleman, J., Jansen, M. P. H. M., Span, P. N., van Staveren, I. L., Massuger, L. F. A. G., Gelder, M. E. M., Sweep, F. C. G. J., Ewing, P. C., van der Burg, M. E. L., Stoter, G., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21599 · Cited by 165 · see citing works
Yang, T., Lu, S., Chao, Y., Sheen, I.-S., Lin, C.-C., Wang, T., Chen, S.-C., Wang, J., Liao, L.-Y., Thomson, J. A., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605856 · Cited by 160 · see citing works
Fernandez, J., Yaman, İ., Mishra, R., Merrick, W. C., Snider, M. D., Lamers, W. H., & Hatzoglou, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009714200 · Cited by 154 · see citing works
Bowles, T. L., Kim, R., Galante, J., Parsons, C. M., Virudachalam, S., Kung, H., & Bold, R. J. (2008) · International Journal of Cancer · doi:10.1002/ijc.23723 · Cited by 153 · see citing works
Plasma arginine concentrations are reduced in cancer patients: evidence for arginine deficiency?
Vissers, Y. L. J., Dejong, C. H. C., Luiking, Y. C., Fearon, K. C. H., MEYENFELDT, M. F. V., & Deutz, N. E. P. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.5.1142 · Cited by 148 · see citing works
Tsai, W.-B., Aiba, I., Lee, S.-Y., Feun, L. G., Savaraj, N., & Kuo, M. T. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0794 · Cited by 141 · see citing works
Tumor iNOS predicts poor survival for stage III melanoma patients
Ekmekçioglu, S., Ellerhorst, J. A., Prieto, V. G., Johnson, M. M., Broemeling, L. D., & Grimm, E. A. (2006) · International Journal of Cancer · doi:10.1002/ijc.21767 · Cited by 135 · see citing works
Nicholson, L. J., Smith, P. R., Hiller, L., Szlosarek, P. W., Kimberley, C., Sehouli, J., Koensgen, D., Mustea, A., Schmid, P., & Crook, T. (2009) · International Journal of Cancer · doi:10.1002/ijc.24546 · Cited by 133 · see citing works
Self-citationSu, T. S., Bock, H. G., O’Brien, W. E., & Beaudet, A. L. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68480-2 · Cited by 128 · see citing works
Metabolic Targeting as an Anticancer Strategy: Dawn of a New Era?
Pan, J. G., & Mak, T. W. (2007) · Science s STKE · doi:10.1126/stke.3812007pe14 · Cited by 128 · see citing works
Pegylated arginine deiminase: a novel anticancer enzyme agent
Feun, L. G., & Savaraj, N. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.7.815 · Cited by 118 · see citing works
Cancer incidence in British vegetarians
Key, T. J., Appleby, P. N., Spencer, E. A., Travis, R. C., Allen, N. E., Thorogood, M., & Mann, J. I. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605098 · Cited by 116 · see citing works
Insulin and the arginine paradox.
Kurz, S. D., & Harrison, D. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119166 · Cited by 110 · see citing works
Rho, J.-H., Qin, S., Wang, J. Y., & Roehrl, M. H. A. (2008) · Journal of Proteome Research · doi:10.1021/pr8000892 · Cited by 100 · see citing works
Goodwin, B. L., Solomonson, L. P., & Eichler, D. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308160200 · Cited by 100 · see citing works
Agmatine: At the Crossroads of the Arginine Pathways
Satriano, J. A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1304.004 · Cited by 96 · see citing works
Induction of spermidine/spermine N1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cancer cells
Babbar, N., Gerner, E. W., & Casero, R. A. (2006) · Biochemical Journal · doi:10.1042/bj20051298 · Cited by 95 · see citing works
Arginine deiminase: a potential inhibitor of angiogenesis and tumour growth
Is, P., Kang, S.-W., Shin, Y.-J., Chae, K.-Y., Park, M.-O., Kim, M. Y., Wheatley, D. N., & Min, B.-H. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601181 · Cited by 95 · see citing works
Tang, C., & Grimm, E. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m310821200 · Cited by 90 · see citing works
New indications and controversies in arginine therapy
Coman, D. J., Yaplito‐Lee, J., & Boneh, A. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.05.007 · Cited by 87 · see citing works
Argininosuccinate Synthetase is Reversibly Inactivated by S-Nitrosylation in Vitro and in Vivo
Hao, G., Xie, L., & Gross, S. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404866200 · Cited by 85 · see citing works
Xie, L., & Gross, S. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16624 · Cited by 81 · see citing works
Nutritional and Metabolic Responses to Arginine Deficiency in Carnivores
Morris, J. G. (1985) · Journal of Nutrition · doi:10.1093/jn/115.4.524 · Cited by 80 · see citing works
Arginine Deiminase Inhibits Cell Proliferation by Arresting Cell Cycle and Inducing Apoptosis
Gong, H., Zölzer, F., Recklinghausen, G. V., Rössler, J. K., Breit, S., Havers, W., Fotsis, T., & Schweigerer, L. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1004 · Cited by 76 · see citing works
Wheatley, D. N. (2004) · Anti-Cancer Drugs · doi:10.1097/00001813-200410000-00002 · Cited by 74 · see citing works
Depletion of Dietary Arginine Inhibits Growth of Metastatic Tumor
Yeatman, T. J. (1991) · Archives of Surgery · doi:10.1001/archsurg.1991.01410350066010 · Cited by 67 · see citing works
Shen, L.-J., Lin, W.-C., Beloussow, K., & Shen, W.-C. (2003) · Cancer Letters · doi:10.1016/s030-43835(02)00693-6 · Cited by 66 · see citing works
White, M. F., & Christensen, H. N. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33986-3 · Cited by 63 · see citing works
Aberrant regulation of argininosuccinate synthetase by TNF‐α in human epithelial ovarian cancer
Szlosarek, P. W., Grimshaw, M. J., Wilbanks, G. D., Hagemann, T., Wilson, J. L., Burke, F., Stamp, G., & Balkwill, F. R. (2007) · International Journal of Cancer · doi:10.1002/ijc.22666 · Cited by 61 · see citing works
Self-citationGiannakakou, P., Villalba, L., Li, H., Poruchynsky, M. S., & Fojo, T. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980105)75:1 · Cited by 60 · see citing works
Gong, H., Pöttgen, C., Stüben, G., Havers, W., Stuschke, M., & Schweigerer, L. (2003) · International Journal of Cancer · doi:10.1002/ijc.11298 · Cited by 53 · see citing works
Role of polyamines in arginine‐dependent colon carcinogenesis in ApcMin/+ mice
Yerushalmi, H. F., Besselsen, D. G., Ignatenko, N. A., Blohm-Mangone, K. A., Padilla‐Torres, J., Stringer, D. E., Guillen, J. M., Holubec, H., Payne, C. M., & Gerner, E. W. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20246 · Cited by 51 · see citing works
Bode, B. P., & Souba, W. W. (1994) · Annals of Surgery · doi:10.1097/00000658-199410000-00001 · Cited by 49 · see citing works
Ma, Q., Wang, Y., Gao, X., Ma, Z., & Song, Z. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0751 · Cited by 46 · see citing works
Wolf, C., Brüss, M., Hanisch, B. W., Göthert, M., von Kügelgen, I., & Molderings, G. J. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.028449 · Cited by 45 · see citing works
Arginine revisited: Minireview article
GRILLO, M. A., & Colombatto, S. (2004) · Amino Acids · doi:10.1007/s00726-004-0081-9 · Cited by 44 · see citing works
Structure of human argininosuccinate synthetase
Karlberg, T., Collins, R., van den Berg, S., Flores, A., Hammarström, M., Högbom, M., Schiavone, L. H., & Uppenberg, J. (2008) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444907067455 · Cited by 40 · see citing works
Krummrei, U., Baulieu, É.-É., & Chambraud, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438007100 · Cited by 40 · see citing works
The role of NO synthases in arginine-dependent small intestinal and colonic carcinogenesis
Yerushalmi, H. F., Besselsen, D. G., Ignatenko, N. A., Blohm-Mangone, K. A., Padilla‐Torres, J., Stringer, D. E., Cui, H., Holubec, H., Payne, C. M., & Gerner, E. W. (2005) · Molecular Carcinogenesis · doi:10.1002/mc.20168 · Cited by 38 · see citing works
Su, Y., & Block, E. R. (1995) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1995.269.5.l581 · Cited by 36 · see citing works
The influence of arginine upon the growth rate of a transplantable tumour in the mouse
Gilroy, E. (1930) · Biochemical Journal · doi:10.1042/bj0240589 · Cited by 35 · see citing works
Brasse‐Lagnel, C., Lavoinne, A., Loeber, D., Fairand, A., Bôle‐Feysot, C., Deniel, N., & Husson, A. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.06047.x · Cited by 35 · see citing works
Lagarde, S. M., van Themaat, P. E. V. L., Moerland, P. D., Gilhuijs-Pederson, L. A., ten Kate, F. J. W., Reitsma, P. H., van Kampen, A. H. C., Zwinderman, A. H., Baas, F., & van Lanschot, J. J. B. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0165-y · Cited by 33 · see citing works
Fontenelle, L. J., & Henderson, J. F. (1969) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(69)90067-1 · Cited by 30 · see citing works
Singh, R., Pervin, S., Wu, G., & Chaudhuri, G. (2001) · Carcinogenesis · doi:10.1093/carcin/22.11.1863 · Cited by 28 · see citing works
Wang, M., Basu, A., Palm, T., Hua, J., Youngster, S. K., Hwang, L. A., Liu, H.-C., Li, X., Peng, P., Zhang, Y., et al. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060198y · Cited by 27 · see citing works
Inoue, Y., Bode, B. P., Copeland, E. M., & Souba, W. W. (1995) · PubMed · Cited by 24 · see citing works
Effect of DNA conformation on cisplatin adduct formation
Bubley, G. J., Xu, J. Y., Kupiec, N., Sanders, D. A., Foss, F. M., O'Brien, M., Emi, Y., Teicher, B. A., & Patierno, S. R. (1996) · Biochemical Pharmacology · doi:10.1016/s0006-2952(95)02256-2 · Cited by 22 · see citing works
Luiking, Y. C., Hallemeesch, M. M., van de Poll, M. C. G., Dejong, C. H. C., de Jonge, W. J., Lamers, W. H., & Deutz, N. E. P. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00055.2008 · Cited by 20 · see citing works
Elevated plasma arginase-1 does not affect plasma arginine in patients undergoing liver resection
van de Poll, M. C. G., Hanssen, S. J., Berbée, M., Deutz, N. E. P., Monbaliu, D. R. L., Buurman, W. A., & Dejong, C. H. C. (2008) · Clinical Science · doi:10.1042/cs20070143 · Cited by 20 · see citing works
Starbuck, W. C., & Busch, H. (1960) · PubMed · Cited by 15 · see citing works
Murakami, A., Kawabata, K., Koshiba, T., Gao, G., Nakamura, Y., Koshimįzu, K., & Ohigashi, H. (2000) · PubMed · Cited by 15 · see citing works
Davidson, J. S., Baumgarten, I. M., & Harley, E. H. (1984) · Experimental Cell Research · doi:10.1016/0014-4827(84)90580-9 · Cited by 11 · see citing works
Accelerated hepatic arginine transport in the tumor-bearing rat
Espat, N. J., Copeland, E. M., & Souba, W. W. (1994) · Annals of Surgical Oncology · doi:10.1007/bf02303559 · Cited by 10 · see citing works
Ott, P. A., Carvajal, R. D., Pandit-Taskar, N. D., Jungbluth, A. A., Hoffman, E. W., Venhaus, R. R., Pan, L., Old, L. J., Pavlick, A. C., & Wolchok, J. D. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.15_suppl.9030 · Cited by 5 · see citing works
Seo, J. H., Sung, H. J., Choi, C. W., Kim, B. S., Shin, S. W., Kim, Y. H., Min, B.-H., & Kim, J. S. (2008) · Investigational New Drugs · doi:10.1007/s10637-007-9105-0 · Cited by 3 · see citing works
Flagged first, then by citations
Research works printed but not linked: 5
- V C 2010 UICC 10970215, 2010, 12, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/ijc.25202, Wiley Online Library on [23/11/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
- Yamamoto T, Terada N, Seiyama A, Nishizawa Y, Akedo H, Kosaka H. Increase in experimental pulmonary metastasis in mice by L-arginine under inhibition of nitric oxide production by NG-nitro-L- arginine methyl ester. Int J Cancer 1998;75: 140-4.
- V C 2010 UICC 10970215, 2010, 12, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/ijc.25202, Wiley Online Library on [23/11/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
- V C 2010 UICC 10970215, 2010, 12, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/ijc.25202, Wiley Online Library on [23/11/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License nuclear proteins of tumors and other tissues in vitro. Cancer Res 1960;20:891-6.
- V C 2010 UICC 10970215, 2010, 12, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/ijc.25202, Wiley Online Library on [23/11/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
Cited by
Sorted by citations
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · see citing works
Autophagy and autophagy-related pathways in cancer
Debnath, J., Gammoh, N., & Ryan, K. M. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00585-z · Cited by 1,443 · see citing works
The hallmarks of cancer metabolism: still emerging
Pavlova, N. N., Zhu, J., & Thompson, C. B. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.01.007 · Cited by 1,418 · see citing works
mTOR signalling and cellular metabolism are mutual determinants in cancer
Mossmann, D., Park, S., & Hall, M. N. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0074-8 · Cited by 1,088 · see citing works
Targeting Metabolism for Cancer Therapy
Luengo, A., Gui, D. Y., & Vander Heiden, M. G. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.08.028 · Cited by 971 · see citing works
Lieu, E. L., Nguyen, T. A., Rhyne, S., & Kim, J. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0375-3 · Cited by 827 · see citing works
How the Warburg effect supports aggressiveness and drug resistance of cancer cells?
Icard, P., Shulman, S. D., Farhat, D., Steyaert, J., Alifano, M., & Lincet, H. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.03.001 · Cited by 648 · see citing works
Metabolic reprogramming in clear cell renal cell carcinoma
Wettersten, H. I., Aboud, O. A., Lara, P. N., & Weiss, R. H. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.59 · Cited by 573 · see citing works
Metabolism of Amino Acids in Cancer
Wei, Z. C., Liu, X., Cheng, C., Yu, W., & Yi, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.603837 · Cited by 439 · see citing works
Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death
García‐Bermúdez, J., Baudrier, L., Bayraktar, E. C., Shen, Y., La, K., Guarecuco, R., Yücel, B., Fiore, D., Tavora, B., Freinkman, E., et al. (2019) · Nature · doi:10.1038/s41586-019-0945-5 · Cited by 424 · see citing works
Altered metabolite levels in cancer: implications for tumour biology and cancer therapy
Sullivan, L. B., Gui, D. Y., & Heiden, M. G. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.85 · Cited by 406 · see citing works
Coupling Krebs cycle metabolites to signalling in immunity and cancer
Ryan, D. G., Murphy, M. P., Frezza, C., Prag, H. A., Chouchani, E. T., O’Neill, L. A., & Mills, E. L. (2018) · Nature Metabolism · doi:10.1038/s42255-018-0014-7 · Cited by 398 · see citing works
Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis
Rabinovich, S., Adler, L., Yizhak, K., Sarver, A., Silberman, A., Agron, S., Stettner, N., Sun, Q., Brandis, A., Helbling, D., et al. (2015) · Nature · doi:10.1038/nature15529 · Cited by 382 · see citing works
Autophagy maintains tumour growth through circulating arginine
Poillet-Perez, L., Xie, X., Zhan, L., Yang, Y., Sharp, D. W., Hu, Z. S., Su, X., Maganti, A., Jiang, C., Lu, W., et al. (2018) · Nature · doi:10.1038/s41586-018-0697-7 · Cited by 363 · see citing works
Novel Insights into Mesothelioma Biology and Implications for Therapy
Yap, T. A., Aerts, J. G., Popat, S., & Fennell, D. A. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.42 · Cited by 324 · see citing works
Self-citationRewiring urea cycle metabolism in cancer to support anabolism
Keshet, R., Szlosarek, P. W., Carracedo, A., & Erez, A. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0054-z · Cited by 322 · see citing works
Self-citationArginine Signaling and Cancer Metabolism
Chen, C., Hsu, S.-C., Ann, D. K., Yen, Y., & Kung, H.-J. (2021) · Cancers · doi:10.3390/cancers13143541 · Cited by 269 · see citing works
Role of tumor and host autophagy in cancer metabolismPreprint
Poillet-Perez, L., & White, E. (2019) · Genes & Development · doi:10.1101/gad.325514.119 · Cited by 269 · see citing works
Targeting arginine-dependent cancers with arginine-degrading enzymes: opportunities and challenges
Phillips, M. M., Sheaff, M. T., & Szlosarek, P. W. (2013) · Cancer Research and Treatment · doi:10.4143/crt.2013.45.4.251 · Cited by 229 · see citing works
Self-citationThe Diverse Functions of Non-Essential Amino Acids in Cancer
Choi, B.-H., & Coloff, J. L. (2019) · Cancers · doi:10.3390/cancers11050675 · Cited by 213 · see citing works
Metabolic reprogramming in renal cancer: Events of a metabolic disease
Chakraborty, S., Balan, M., Sabarwal, A., Choueiri, T. K., & Pal, S. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188559 · Cited by 208 · see citing works
Szlosarek, P. W., Steele, J. P. C., Nolan, L., Gilligan, D., Taylor, P. D., Spicer, J. F., Lind, M., Mitra, S. S., Shamash, J., Phillips, M. M., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.3049 · Cited by 203 · see citing works
Self-citationTargeting Cancer Metabolism: Dietary and Pharmacologic Interventions
Vernieri, C., Casola, S., Foiani, M., Pietrantonio, F., de Braud, F., & Longo, V. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0615 · Cited by 202 · see citing works
Karunakaran, S. K., Ramachandran, S., Coothankandaswamy, V., Elangovan, S., Babu, E., Periyasamy‐Thandavan, S., Gurav, A., Gnana‐Prakasam, J. P., Singh, N., Schoenlein, P. V., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.229518 · Cited by 202 · see citing works
Fischer, G. M., Gopal, Y. N. V., McQuade, J. L., Peng, W., DeBerardinis, R. J., & Davies, M. A. (2017) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12661 · Cited by 195 · see citing works
Modeling cancer metabolism on a genome scale
Yizhak, K., Chaneton, B., Gottlieb, E., & Ruppin, E. (2015) · Molecular Systems Biology · doi:10.15252/msb.20145307 · Cited by 182 · see citing works
MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine Depletion
Chalishazar, M. D., Wait, S. J., Huang, F., Ireland, A. S., Mukhopadhyay, A., Lee, Y., Schuman, S. S., Guthrie, M. R., Berrett, K. C., Vahrenkamp, J. M., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-4140 · Cited by 175 · see citing works
Argininosuccinate synthase: at the center of arginine metabolism.
(2011) · Europe PMC (PubMed Central) · Cited by 176 · see citing works
Arginine—Dual roles as an onconutrient and immunonutrient
Albaugh, V. L., Pinzon‐Guzman, C., & Barbul, A. (2016) · Journal of Surgical Oncology · doi:10.1002/jso.24490 · Cited by 173 · see citing works
Syed, N., Langer, J., Janczar, K., Singh, P., Nigro, C. L., Lattanzio, L., Coley, H. M., Hatzimichael, E. C., Bomalaski, J. S., Szlosarek, P. W., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2012.197 · Cited by 167 · see citing works
Self-citationKremer, J. C., Prudner, B. C., Lange, S. E. S., Bean, G. R., Schultze, M., Brashears, C. B., Radyk, M. D., Redlich, N. J., Tzeng, S., Kami, K., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.077 · Cited by 160 · see citing works
Yang, T., Lu, S., Chao, Y., Sheen, I.-S., Lin, C.-C., Wang, T., Chen, S.-C., Wang, J., Liao, L.-Y., Thomson, J. A., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605856 · Cited by 160 · see citing works
Arginine and the metabolic regulation of nitric oxide synthesis in cancer
Keshet, R., & Erez, A. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.033332 · Cited by 159 · see citing works
Arginine metabolism and deprivation in cancer therapy
Zou, S., Wang, X., Liu, P., Ke, C., & Xu, S. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109210 · Cited by 159 · see citing works
Metabolic pathways of L-arginine and therapeutic consequences in tumors
Szefel, J., Danielak, A., & Kruszewski, W. J. (2018) · Advances in Medical Sciences · doi:10.1016/j.advms.2018.08.018 · Cited by 156 · see citing works
Huang, H.-Y., Wu, W.-R., Wang, Y.-H., Wang, J., Fang, F.-M., Tsai, J.-W., Li, S.-H., Hung, H.-C., Yu, S.-C., Lan, J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2641 · Cited by 154 · see citing works
Arginine Metabolism in Bacterial Pathogenesis and Cancer Therapy
Xiong, L., Teng, J. L. L., Botelho, M. G., Lo, R. C., Lau, S. K. P., & Woo, P. C. Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030363 · Cited by 152 · see citing works
Citrulline and nitrogen homeostasis: an overview
Breuillard, C., Cynober, L., & Moinard, C. (2015) · Amino Acids · doi:10.1007/s00726-015-1932-2 · Cited by 153 · see citing works
Allen, M. D., Luong, P., Hudson, C. D., Leyton, J., Delage, B., Ghazaly, E. A., Cutts, R. J., Yuan, M., Syed, N., Nigro, C. L., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1702 · Cited by 153 · see citing works
Self-citationTumour metabolism and its unique properties in prostate adenocarcinoma
Bader, D. A., & McGuire, S. E. (2020) · Nature Reviews Urology · doi:10.1038/s41585-020-0288-x · Cited by 154 · see citing works
Delage, B., Luong, P., Maharaj, L., Ó’Riain, C., Syed, N., Crook, T., Hatzimichael, E. C., Papoudou‐Bai, A., Mitchell, T. J., Whittaker, S. J., et al. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.83 · Cited by 144 · see citing works
Self-citationMiraki‐Moud, F., Ghazaly, E. A., Ariza‐McNaughton, L., Hodby, K. A., Clear, A. J., Anjos‐Afonso, F., Liapis, K., Grantham, M., Sohrabi, F., Cavenagh, J. D., et al. (2015) · Blood · doi:10.1182/blood-2014-10-608133 · Cited by 139 · see citing works
Self-citationThe roles of arginases and arginine in immunity
Canè, S., Geiger, R., & Bronte, V. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01098-2 · Cited by 135 · see citing works
Icard, P., & Lincet, H. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.07.001 · Cited by 123 · see citing works
Metabolic Plasticity of Melanoma Cells and Their Crosstalk With Tumor Microenvironment
Avagliano, A., Fiume, G., Pelagalli, A., Sanità, G., Ruocco, M. R., Montagnani, S., & Arcucci, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00722 · Cited by 122 · see citing works
Long, Y., Tsai, W.-B., Wangpaichitr, M., Tsukamoto, T., Savaraj, N., Feun, L. G., & Kuo, M. T. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0302 · Cited by 121 · see citing works
Beddowes, E. J., Spicer, J. F., Chan, P. Y., Khadeir, R. S., Corbacho, J. G., Repana, D., Steele, J. P. C., Schmid, P., Szyszko, T. A., Cook, G., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.3230 · Cited by 121 · see citing works
Self-citationArginine is an epigenetic regulator targeting TEAD4 to modulate OXPHOS in prostate cancer cells
Chen, C., Hsu, S.-C., Chung, T.-Y., Chu, C.-Y., Wang, H.-J., Hsiao, P., Yeh, S.-D., Ann, D. K., Yen, Y., & Kung, H.-J. (2021) · Nature Communications · doi:10.1038/s41467-021-22652-9 · Cited by 119 · see citing works
Kelly, M. P., Jungbluth, A. A., Wu, B.-W., Bomalaski, J. S., Old, L. J., & Ritter, G. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.524 · Cited by 117 · see citing works
Nonessential amino acid metabolism in breast cancer
Geck, R. C., & Toker, A. (2016) · Advances in Biological Regulation · doi:10.1016/j.jbior.2016.01.001 · Cited by 115 · see citing works
Glutamine‐fueled mitochondrial metabolism is decoupled from glycolysis in melanoma
Filipp, F. V., Ratnikov, B. I., Ingeniis, J. D., Smith, J. W., Osterman, A. L., & Scott, D. A. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12000 · Cited by 107 · see citing works
Targeting nucleotide metabolism as the nexus of viral infections, cancer, and the immune response
Ariav, Y., Ch’ng, J., Christofk, H. R., Ron‐Harel, N., & Erez, A. (2021) · Science Advances · doi:10.1126/sciadv.abg6165 · Cited by 109 · see citing works
Arginine and Arginases Modulate Metabolism, Tumor Microenvironment and Prostate Cancer Progression
Matos, A., Carvalho, M., Bicho, M., & Ribeiro, R. J. T. (2021) · Nutrients · doi:10.3390/nu13124503 · Cited by 106 · see citing works
Metabolic dysregulation in monogenic disorders and cancer — finding method in madness
Erez, A., & DeBerardinis, R. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3949 · Cited by 105 · see citing works
Udenigwe, C. C., Adebiyi, A., Doyen, A., Li, H., Bazinet, L., & Aluko, R. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2011.11.024 · Cited by 92 · see citing works
Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia
Giskeødegård, G. F., Hansen, A. F., Bertilsson, H., González, S. V., Kristiansen, K. A., Bruheim, P., Mjøs, S. A., Angelsen, A., Bathen, T. F., & Tessem, M. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.411 · Cited by 103 · see citing works
Molecular basis and current strategies of therapeutic arginine depletion for cancer
Fultang, L., Vardon, A., Santo, C. D., & Mussai, F. (2016) · International Journal of Cancer · doi:10.1002/ijc.30051 · Cited by 98 · see citing works
Werner, A., Koschke, M., Leuchtner, N., Luckner‐Minden, C., Habermeier, A., Rupp, J., Heinrich, C., Conradi, R., Closs, E. I., & Munder, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00864 · Cited by 98 · see citing works
Keshet, R., Lee, J. S., Adler, L. N., Iraqi, M., Ariav, Y., Lim, L. Q. J., Lerner, S., Rabinovich, S., Oren, R., Katzir, R., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0106-7 · Cited by 98 · see citing works
Bean, G. R., Kremer, J. C., Prudner, B. C., Schenone, A. D., Yao, J.-C., Schultze, M., Chen, D. Y., Tanas, M. R., Adkins, D. R., Bomalaski, J. S., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.232 · Cited by 97 · see citing works
Multiligand Specificity and Wide Tissue Expression of GPRC6A Reveals New Endocrine Networks
Pi, M., & Quarles, L. D. (2012) · Endocrinology · doi:10.1210/en.2011-2117 · Cited by 95 · see citing works
The context-specific roles of urea cycle enzymes in tumorigenesis
Hajaj, E., Sciacovelli, M., Frezza, C., & Erez, A. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.005 · Cited by 93 · see citing works
Narayanan, S. P., Rojas, M., Suwanpradid, J., Toque, H. A., Caldwell, R. W., & Caldwell, R. B. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.06.002 · Cited by 94 · see citing works
Metabolism in the Tumor Microenvironment
Lau, A. N., & Heiden, M. G. V. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030419-033333 · Cited by 89 · see citing works
Microbial therapeutic enzymes: A promising area of biopharmaceuticals
Vachher, M., Sen, A., Kapila, R., & Nigam, A. (2021) · Current Research in Biotechnology · doi:10.1016/j.crbiot.2021.05.006 · Cited by 89 · see citing works
Alexandrou, C., Al-Aqbi, S. S., Higgins, J. A., Boyle, W., Karmokar, A., Andreadi, C., Luo, J., Moore, D. A., Viskaduraki, M., Blades, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-30591-7 · Cited by 87 · see citing works
Riess, C., Shokraie, F., Classen, C. F., Kreikemeyer, B., Fiedler, T., Junghanß, C., & Maletzki, C. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495382 · Cited by 87 · see citing works
Nutritional Interventions in Cancer Cachexia: Evidence and Perspectives From Experimental Models
van de Worp, W. R. P. H., Schols, A. M. W. J., Theys, J., van Helvoort, A., & LANGEN, R. C. J. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.601329 · Cited by 92 · see citing works
Targeting extracellular nutrient dependencies of cancer cells
García‐Bermúdez, J., Williams, R. T., Guarecuco, R., & Birsoy, K. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.11.011 · Cited by 87 · see citing works
Dhankhar, R., Gupta, V., Kumar, S., Kapoor, R. K., & Gulati, P. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10432-2 · Cited by 85 · see citing works
Zhang, J., Wang, S., Guo, X., Lu, Y., Liu, X., Jiang, M., Li, X., Qin, B., Luo, Z., Liu, H., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c05408 · Cited by 85 · see citing works
GPRC6A regulates prostate cancer progression
Pi, M., & Quarles, L. D. (2011) · The Prostate · doi:10.1002/pros.21442 · Cited by 80 · see citing works
Mitochondrial Flexibility of Breast Cancers: A Growth Advantage and a Therapeutic Opportunity
Avagliano, A., Ruocco, M. R., Aliotta, F., Belviso, I., Accurso, A., Masone, S., Montagnani, S., & Arcucci, A. (2019) · Cells · doi:10.3390/cells8050401 · Cited by 85 · see citing works
Tumor microenvironment: recent advances in understanding and its role in modulating cancer therapies
Shah, D. D., Chorawala, M. R., Raghani, N. R., Patel, R., Fareed, M., Kashid, V. A., & Prajapati, B. G. (2025) · Medical Oncology · doi:10.1007/s12032-025-02641-4 · Cited by 78 · see citing works
Metabolic reprogramming of clear cell renal cell carcinoma
Zhu, H., Wang, X., Lu, S., & Ou, K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1195500 · Cited by 80 · see citing works
Szlosarek, P. W., Luong, P., Phillips, M. M., Baccarini, M., Ellis, S. M., Szyszko, T. A., Sheaff, M. T., & Avril, N. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.1784 · Cited by 74 · see citing works
Self-citationMott, F. E. (2012) · PubMed Central · Cited by 71 · see citing works
Dudka, I., Thysell, E., Lundquist, K., Antti, H., Iglesias‐Gato, D., Flores‐Morales, A., Bergh, A. R. J., Wikström, P., & Gröbner, G. (2020) · BMC Cancer · doi:10.1186/s12885-020-06908-z · Cited by 70 · see citing works
Zou, Z., Hu, X., Luo, T., Ming, Z., Chen, X., Li, X., Luo, W., Li, J., Xu, N., Chen, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22235-8 · Cited by 70 · see citing works
Arginine Metabolism and Its Potential in Treatment of Colorectal Cancer
Du, T., & Han, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.658861 · Cited by 70 · see citing works
Hall, P. E., Lewis, R., Syed, N., Shaffer, R. E., Evanson, J., Ellis, S. M., Williams, M., Feng, X., Johnston, A. L., Thomson, J. A., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3729 · Cited by 70 · see citing works
Self-citationThe metabolic cooperation between cells in solid cancer tumors
Icard, P., Kafara, P., Steyaert, J., Schwartz, L. H., & Lincet, H. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.06.002 · Cited by 69 · see citing works
McAlpine, J. A., Lu, H.-T., Wu, K. C., Knowles, S. K., & Thomson, J. A. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-621 · Cited by 67 · see citing works
Kim, S., Lee, M., Song, Y., Lee, S., Choi, I., Park, I.-S., Kim, J., Kim, J., Kim, K. M., & Seo, H. R. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01912-y · Cited by 67 · see citing works
Metabolomics profiling in plasma samples from glioma patients correlates with tumor phenotypes
Zhao, H., Heimberger, A. B., Lu, Z., Wu, X., Hodges, T. R., Song, R., & Shen, J. (2016) · Oncotarget · doi:10.18632/oncotarget.7974 · Cited by 67 · see citing works
Lan, J., Tai, H., Lee, S., Chen, T., Huang, H., & Li, C. (2013) · Tumor Biology · doi:10.1007/s13277-013-1020-8 · Cited by 66 · see citing works
Tsai, C., Chi, H., Chi, L., Yang, H., Tsai, M.-M., Lee, K., Huang, H., Chou, L., Cheng, A., Yang, C., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201700094r · Cited by 65 · see citing works
Khoury, O., Ghazale, N., Stone, E. M., El‐Sibai, M., Frankel, A. E., & Abi‐Habib, R. J. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1698-5 · Cited by 64 · see citing works
A prospective study of serum metabolites and glioma risk
Huang, J., Weinstein, S. J., Kitahara, C. M., Karoly, E. D., Sampson, J. N., & Albanes, D. (2017) · Oncotarget · doi:10.18632/oncotarget.19705 · Cited by 64 · see citing works
Fiedler, T., Strauß, M., Hering, S., Redanz, U., William, D., Rosche, Y., Classen, C. F., Kreikemeyer, B., Linnebacher, M., & Maletzki, C. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1026478 · Cited by 63 · see citing works
El‐Sayed, A. S. A., Shindia, A. A., Abou-Zeid, A. A., Yassin, A. M., Sitohy, M. Z., & Sitohy, B. (2019) · Enzyme and Microbial Technology · doi:10.1016/j.enzmictec.2019.109432 · Cited by 61 · see citing works
Emerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading?
Cantini, L., Hassan, R., Sterman, D. H., & Aerts, J. G. J. V. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00343 · Cited by 59 · see citing works
Crump, N. T., Hadjinicolaou, A. V., Meng, X., Walsby-Tickle, J., Gileadi, U., Chen, J., Setshedi, M., Olsen, L. R., Lau, I., Godfrey, L., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109101 · Cited by 60 · see citing works
Melaiu, O., Cristaudo, A., Melissari, E., Russo, M. D., Bonotti, A., Bruno, R., Foddis, R., Gemignani, F., Pellegrini, S., & Landi, S. (2011) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2011.12.003 · Cited by 60 · see citing works
Arginine: Challenges and opportunities of this two-faced molecule in cancer therapy
Jahani, M., Noroznezhad, F., & Mansouri, K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.109 · Cited by 60 · see citing works
The tumor microenvironment in renal cell cancer
Mier, J. W. (2019) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000512 · Cited by 57 · see citing works
Argininosuccinate synthase 1 is an intrinsic Akt repressor transactivated by p53
Miyamoto, T., Lo, P. H. Y., Saichi, N., Ueda, K., Hirata, M., Tanikawa, C., & Matsuda, K. (2017) · Science Advances · doi:10.1126/sciadv.1603204 · Cited by 58 · see citing works
Shan, Y., Hsu, H., Lai, M.-D., Yen, M., Chen, W.-C., Fang, J.-H., Weng, T., & Chen, Y. (2015) · Scientific Reports · doi:10.1038/srep09783 · Cited by 58 · see citing works
Locke, M., Ghazaly, E. A., Freitas, M. O., Mitsinga, M., Lattanzio, L., Nigro, C. L., Nagano, A., Wang, J., Chelala, C., Szlosarek, P. W., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.097 · Cited by 57 · see citing works
Self-citationEfficacy of arginine depletion by ADI-PEG20 in an intracranial model of GBM
Przystal, J. M., Hajji, N., Khozoie, C., Renziehausen, A., Zeng, Q., Abaitua, F., Hajitou, A., Suwan, K., Want, E. J., Bomalaski, J. S., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1195-4 · Cited by 57 · see citing works
Self-citation
- Authors
- Delage, B., Fennell, D. A., Nicholson, L., McNeish, I., Lemoine, N. R., Crook, T., & Szlosarek, P. W.
- Affiliations
- Queen Mary University of London (GB)
- Queen's University Belfast (GB)
- King's College London (GB)
- St Bartholomew's Hospital (GB)
- Imperial College London (GB)
- Corresponding author
- Szlosarek, Peter W.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2010-04-09
- Volume
- 126
- Issue
- 12
- Pages
- 2762-2772
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2027449497
- Cited by
- 441
- References
- 86
- Citations by year
- 2026: 26 · 2025: 38 · 2024: 28 · 2023: 30 · 2022: 32 · 2021: 51 · 2020: 26 · 2019: 35 · 2018: 32 · 2017: 26 · 2016: 25 · 2015: 20 · 2014: 25 · 2013: 17 · 2012: 12
- FWCI
- 1.61
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- International Journal of Cancer (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Leicester Research Archive (University of Leicester) (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- Funders
- Cancer Research UK (C12522/A8632, 12008)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Cancer Research and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Polyamine Metabolism and Applications
- Keywords
- arginine deprivation, argininosuccinate synthetase, ASS1, arginine auxotrophy, pegylated arginine deiminase, epigenetic silencing, chemoresistance, platinum resistance, ovarian cancer, tumor microenvironment, inflammatory cytokines, hepatocellular carcinoma, melanoma, malignant pleural mesothelioma, prostate cancer, kidney cancer, cancer therapy
- MeSH terms
- Animals, Arginine, Argininosuccinate Synthase, Humans, Neoplasms, Prognosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
